Natco Pharma gets EIR for API division in Chennai

13 Feb 2026 Evaluate

Natco Pharma has received Establishment Inspection Report (EIR) from U.S. Food and Drug Administration (USFDA) for Active Pharmaceutical Ingredient (API) division located in Manali, Chennai. The said facility has received Voluntary Action Indicated (VAI) classification. 

The inspection had conducted from November 17, 2025 to November 21, 2025. The Company received seven observations in the Form-483.

Natco Pharma was promoted as a private company to be in the business of research, developing, manufacturing and marketing of pharmaceutical substances and finished dosage forms for Indian and International markets.

Natco Pharma Share Price

822.10 -17.80 (-2.12%)
13-Feb-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1698.10
Dr. Reddys Lab 1267.60
Cipla 1330.85
Zydus Lifesciences 904.85
Lupin 2199.20
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×